Runben Biotechnology Co., Ltd. (SHA:603193)

Runben Biotechnology Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14,521	9,447	7,356	-	-	-
Market Cap Growth	114.91%	28.44%	-	-	-	-
Enterprise Value	13,137	9,054	6,808	-	-	-
Last Close Price	35.89	23.21	17.79	-	-	-
PE Ratio	47.35	31.47	32.54	-	-	-
Forward PE	36.33	26.27	26.80	-	-	-
PS Ratio	10.44	7.17	7.12	-	-	-
PB Ratio	6.83	4.54	3.83	-	-	-
P/TBV Ratio	7.01	4.66	3.87	-	-	-
P/FCF Ratio	77.64	51.62	30.79	-	-	-
P/OCF Ratio	53.67	36.73	29.13	-	-	-
EV/Sales Ratio	9.44	6.87	6.59	-	-	-
EV/EBITDA Ratio	37.95	27.62	25.94	-	-	-
EV/EBIT Ratio	40.39	29.38	28.06	-	-	-
EV/FCF Ratio	70.24	49.47	28.50	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.02	-
Debt / EBITDA Ratio	0.01	0.01	0.02	0.04	0.07	-
Debt / FCF Ratio	0.01	0.02	0.02	0.06	-	-
Asset Turnover	0.64	0.62	0.73	1.16	1.26	2.01
Inventory Turnover	3.58	5.23	4.64	4.93	5.40	5.64
Quick Ratio	8.26	10.58	16.93	3.97	3.64	3.72
Current Ratio	9.71	11.63	18.04	5.28	4.56	5.85
Return on Equity (ROE)	15.14%	15.00%	17.10%	24.93%	29.72%	48.88%
Return on Assets (ROA)	9.31%	9.09%	10.66%	15.06%	17.69%	30.29%
Return on Capital (ROIC)	9.95%	9.61%	11.42%	17.02%	19.86%	34.46%
Return on Capital Employed (ROCE)	15.30%	14.80%	12.60%	24.30%	22.90%	42.40%
Earnings Yield	2.13%	3.18%	3.07%	-	-	-
FCF Yield	1.29%	1.94%	3.25%	-	-	-
Dividend Yield	1.28%	1.77%	0.96%	-	-	-
Payout Ratio	44.04%	45.32%	-	2.15%	25.65%	-
Buyback Yield / Dilution	-12.06%	-14.85%	-3.71%	-1.61%	-9.69%	-499.54%
Total Shareholder Return	-10.81%	-13.09%	-2.76%	-1.61%	-9.69%	-499.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.